Aegerion Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
04 Nov 2016	Form 3: Orloff John J, EVP, Research and Development No securities owned
20 Sep 2016	Form 3: Menes Remi A, Global Chief Commercial Off. No securities owned
08 Sep 2016	Form 3: Buono Linda, Sr. VP, Human Resources
24 Jun 2016	Form 3: Aegerion Pharmaceuticals, Inc., 10% owner · NOVELION THERAPEUTICS INC. Holds 0 shares of Common Shares
23 Jun 2016	Form 3: Qlt INC/BC, 10% owner Holds 0 shares of Common Stock, par value $0.001 per share
07 Jun 2016	Form 3: Chan Barbara Y, See Remarks No securities owned
11 Jan 2016	Form 3: Szela Mary T, Director No securities owned
02 Dec 2015	Form 3: Louis Roger, See Remarks No securities owned
13 Nov 2015	Form 3: Broadfin Healthcare Master Fund Ltd, 10% owner and 2 others Holds 3,470,191 shares of Common Stock, $0.001 par value
18 Sep 2015	Form 3: Harshbarger Benjamin, General Counsel and Secretary
18 Sep 2015	Form 3: Stern Donald K, Director No securities owned
04 Sep 2015	Form 3: Curtis Eric, President, U.S. Commercial
10 Jul 2015	Form 3: Perry Gregory D, Chief Financial Officer No securities owned
08 Jun 2015	Form 3: Aubuchon David, Chief Financial Officer
10 Apr 2015	Form 3: Plutzky Jorge Md, Director No securities owned
03 Apr 2015	Form 3: Andrews William T., See Remarks Holds 4,660 shares of Common Stock
03 Apr 2015	Form 3: Weger Mary, Chief Performance Officer Holds 3,038 shares of Common Stock
30 Apr 2013	Form 3: Vanlent Anne, Director No securities owned
03 Dec 2012	Form 3: Perceptive Advisors Llc, 10% owner and 2 others Holds 2,415,293 shares of COMMON STOCK
03 Dec 2012	Form 3: Perceptive Advisors Llc, 10% owner and 2 others Holds 2,594,733 shares of COMMON STOCK

Comments